{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-002863","form_type":"8-K","ticker":"OACC","cik":"0002029769","company_name":"Oaktree Acquisition Corp. III Life Sciences","filed_at":"2025-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.830168+00:00","generated_at":"2026-05-28T09:24:52.518073+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Oaktree Acquisition Corp III board changes: Frank resigns, Kumar chairman, Pardesi appointed director","bullets":["John Frank resigned from the board effective Jan 6, 2025, not due to any disagreement with the company.","Aman Kumar, an existing director, was appointed as the new chairman of the board.","CEO Zaid Pardesi was appointed as a Class III director, term expiring at third annual shareholder meeting.","Pardesi and Kumar have material interests in the Sponsor Oaktree Acquisition Holdings III LS, as previously disclosed in the IPO prospectus.","No arrangements or family relationships exist between Pardesi and other directors or executive officers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-002863","json":"https://secwatch.observer/filing/0001193125-25-002863.json","markdown":"https://secwatch.observer/filing/0001193125-25-002863.md","text":"https://secwatch.observer/filing/0001193125-25-002863.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/d920585d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T09:24:52.518073+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ab99d54ebf","claim":"John Frank resigned as director at Oaktree Acquisition Corp. III Life Sciences.","evidence_excerpt":"On January 6, 2025, John Frank resigned from the board of directors (the “Board”) of Oaktree Acquisition Corp. III Life Sciences (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"c3749109db","claim":"Aman Kumar was appointed as chairman of the board at Oaktree Acquisition Corp. III Life Sciences.","evidence_excerpt":"the Board appointed (i) Aman Kumar, currently a director of the Company, as the new chairman of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"chairman of the board"}],"fact_type":"executive_change"},{"claim_id":"e81e182d79","claim":"Zaid Pardesi was appointed as director at Oaktree Acquisition Corp. III Life Sciences.","evidence_excerpt":"and (ii) Zaid Pardesi, the Company’s Chief Executive Officer, as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2029769/000119312525002863/0001193125-25-002863-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}